SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-20-019070
Filing Date
2020-08-26
Accepted
2020-08-26 08:05:59
Documents
4
Period of Report
2020-08-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nt10014149x6_8k.htm 8-K 20882
2 EXHIBIT 99.1 nt10014149x6_ex99-1.htm EX-99.1 14401
3 image0.jpg GRAPHIC 64463
4 image1.jpg GRAPHIC 469080
  Complete submission text file 0001140361-20-019070.txt   771842
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc (Filer) CIK: 0001411690 (see all company filings)

IRS No.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 201134123
SIC: 3826 Laboratory Analytical Instruments